Talia Schwartz, MS, CCC-SLP, Author at Dysphagia Cafe

3 POSTS 0 COMMENTS

Talia H. Schwartz is currently a senior Speech Language Pathologist at New York Presbyterian- Columbia Irving Medical Center in Manhattan. She specializes in dysphagia diagnostics and rehabilitation, as well as management of the head and neck cancer population. Experience includes but is not limited to: total laryngectomy and TEP troubleshooting, trach/ventilator-dependence, polytrauma, burn cases, pulmonary, cardiac, and neurological diseases. Competencies include MBSimp and FEES. She has supervised graduate level students, is a member of SIG13 and NYCDG, and has received multiple ASHA ACE awards for dedication to continuing education.

Leadership: Empowering and championing by example

Talia Schwartz, MS, CCC-SLP - January 2, 2021

Covid-land-The sequel: Navigating the bridge from acute care to LTACH

Talia Schwartz, MS, CCC-SLP - May 14, 2020

Covid-land, NYC: Reflections from the front lines

Talia Schwartz, MS, CCC-SLP - April 22, 2020

Scroll for Important Safety Information

INDICATIONS AND USAGE:

VARIBAR ® THIN HONEY (barium sulfate) oral suspension, VARIBAR ® NECTAR (barium sulfate) oral suspension, and VARIBAR ® THIN LIQUID (barium sulfate) for oral suspension, are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients. VARIBAR ® HONEY (barium sulfate) oral suspension and VARIBAR ® PUDDING (barium sulfate) oral paste are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients 6 months of age and older.

IMPORTANT SAFETY INFORMATION:
For Oral Administration. This product should not be used in patients with known or suspected perforation of the GI tract, known obstruction of the GI tract, high risk of aspiration, or hypersensitivity to barium sulfate products. Rarely, severe allergic reactions of anaphylactoid nature have been reported following administration of barium sulfate contrast agents. Aspiration may occur during the modified barium swallow examination, monitor the patient for aspiration.

Please consult full Prescribing Information for VARIBAR products by clicking HERE.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit FDA or call 1-800-FDA-1088.